The impact of the overuse of short-acting β2-agonists on the risk of sepsis and septic shock
Journal
The Journal of allergy and clinical immunology
Date Issued
2022-01-30
Author(s)
Abstract
Overuse of short-acting β-agonists (SABAs) could be associated with increased acute exacerbations and mortality in patients with asthma. However, the role of SABAs in sepsis has not been well studied.
Subjects
Short-acting β-agonist; asthma; overuse; sepsis; septic shock
SDGs
Type
journal article